Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 387

1.

Field responsive mechanical metamaterials.

Jackson JA, Messner MC, Dudukovic NA, Smith WL, Bekker L, Moran B, Golobic AM, Pascall AJ, Duoss EB, Loh KJ, Spadaccini CM.

Sci Adv. 2018 Dec 7;4(12):eaau6419. doi: 10.1126/sciadv.aau6419. eCollection 2018 Dec.

PMID:
30539147
2.

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.

Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H.

Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24.

PMID:
30507409
3.

Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018.

Davies NECG, Ashford G, Bekker LG, Chandiwana N, Cooper D, Dyer SJ, Jankelowitz L, Mhlongo O, Mnyani CN, Mulaudzi MB, Moorhouse M, Myer L, Patel M, Pleaner M, Ramos T, Rees H, Schwartz S, Smit J, van Zyl DS.

South Afr J HIV Med. 2018 Oct 18;19(1):915. doi: 10.4102/sajhivmed.v19i1.915. eCollection 2018. No abstract available.

4.

Scaling up pre-exposure prophylaxis in sub-Saharan Africa.

Ahmed N, Pike C, Bekker LG.

Curr Opin Infect Dis. 2018 Nov 16. doi: 10.1097/QCO.0000000000000511. [Epub ahead of print]

PMID:
30461452
5.

"Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.

Thabethe S, Slack C, Lindegger G, Wilkinson A, Wassenaar D, Kerr P, Bekker LG, Mngadi K, Newman PA.

J Empir Res Hum Res Ethics. 2018 Dec;13(5):525-536. doi: 10.1177/1556264618804740.

6.
7.

What do South African adolescents want in a sexual health service? Evidence from the South African Studies on HIV in Adolescents (SASHA) project.

Smith P, Marcus R, Bennie T, Nkala B, Nchabeleng M, Latka MH, Gray G, Wallace M, Bekker LG.

S Afr Med J. 2018 Jul 25;108(8):677-681. doi: 10.7196/SAMJ.2018.v108i8.13013.

8.

Defining adolescence: priorities from a global health perspective.

Kinghorn A, Shanaube K, Toska E, Cluver L, Bekker LG.

Lancet Child Adolesc Health. 2018 May;2(5):e10. doi: 10.1016/S2352-4642(18)30096-8. Epub 2018 Mar 23. No abstract available.

PMID:
30169271
9.

Perspectives of South African youth in the development of an implant for HIV prevention.

Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A.

J Int AIDS Soc. 2018 Aug;21(8):e25170. doi: 10.1002/jia2.25170.

10.

Comparing Youth-Friendly Health Services to the Standard of Care Through "Girl Power-Malawi": A Quasi-Experimental Cohort Study.

Rosenberg NE, Bhushan NL, Vansia D, Phanga T, Maseko B, Nthani T, Libale C, Bamuya C, Kamtsendero L, Kachigamba A, Myers L, Tang J, Hosseinipour MC, Bekker LG, Pettifor AE.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):458-466. doi: 10.1097/QAI.0000000000001830.

PMID:
30085953
11.

HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.

Kaplan R, Hermans S, Caldwell J, Jennings K, Bekker LG, Wood R.

BMC Infect Dis. 2018 Jul 31;18(1):356. doi: 10.1186/s12879-018-3256-9.

12.

Expert consensus statement on the science of HIV in the context of criminal law.

Barré-Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P.

J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161.

13.

Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection.

Balle C, Lennard K, Dabee S, Barnabas SL, Jaumdally SZ, Gasper MA, Maseko V, Mbulawa ZZA, Williamson AL, Bekker LG, Lewis DA, Passmore JS, Jaspan HB.

Sci Rep. 2018 Jul 23;8(1):11109. doi: 10.1038/s41598-018-29320-x.

14.

The global response and unmet actions for HIV and sex workers.

Shannon K, Crago AL, Baral SD, Bekker LG, Kerrigan D, Decker MR, Poteat T, Wirtz AL, Weir B, Boily MC, Butler J, Strathdee SA, Beyrer C.

Lancet. 2018 Aug 25;392(10148):698-710. doi: 10.1016/S0140-6736(18)31439-9. Epub 2018 Jul 20. Review.

PMID:
30037733
15.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C.

Lancet. 2018 Jul 28;392(10144):312-358. doi: 10.1016/S0140-6736(18)31070-5. Epub 2018 Jul 20. Review. No abstract available.

PMID:
30032975
16.

The use of liver slices from the Cape vulture (Gyps coprotheres) to better understand the role of liver toxicity of non-steroidal anti-inflammatory drugs (NSAIDs) in vultures.

Adawaren EO, Mukandiwa L, Njoya EM, Bekker L, Duncan N, Naidoo V.

Environ Toxicol Pharmacol. 2018 Sep;62:147-155. doi: 10.1016/j.etap.2018.07.001. Epub 2018 Jul 4.

PMID:
30025357
17.

Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.

Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, Jaumdally SZ, Williamson AL, Little F, Van Damme L, Ahmed K, Crucitti T, Abdellati S, Bekker LG, Gray G, Dietrich J, Jaspan H, Passmore JS.

Sex Transm Infect. 2018 Jul 17. pii: sextrans-2017-053506. doi: 10.1136/sextrans-2017-053506. [Epub ahead of print]

PMID:
30018088
18.

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.

Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, Gurunathan S, DiazGranados CA, Andersen P, Kromann I, Evans T, Ellis RD, Landry B, Hokey DA, Hopkins R, Ginsberg AM, Scriba TJ, Hatherill M; C-040-404 Study Team.

N Engl J Med. 2018 Jul 12;379(2):138-149. doi: 10.1056/NEJMoa1714021.

19.

Using Observational Data to Inform HIV Policy Change for Children and Youth.

Sohn AH, Judd A, Mofenson L, Vicari M, Jerene D, Leroy V, Bekker LG, Davies MA.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1:S22-S26. doi: 10.1097/QAI.0000000000001745.

20.

Ensuring Children and Adolescents Are Not Left Behind.

Bekker LG, Siberry GK, Hirnschall G.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1:S1-S2. doi: 10.1097/QAI.0000000000001751. No abstract available.

21.

In memoriam: Professor David Cooper (1949 to 2018).

Kippax S, Mayer KH, Sohn A, Bekker LG, Pozniak A, Beyrer C, Lewin SR, Ryan O, Phanuphak P, Kirby M.

J Int AIDS Soc. 2018 Jun;21(6):e25152. doi: 10.1002/jia2.25152. No abstract available.

22.

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, Allen M, Malahleha M, Mngadi K, Daniels B, Innes C, Bentley C, Frahm N, Morris DE, Morris L, Mkhize NN, Montefiori DC, Sarzotti-Kelsoe M, Grant S, Yu C, Mehra VL, Pensiero MN, Phogat S, DiazGranados CA, Barnett SW, Kanesa-Thasan N, Koutsoukos M, Michael NL, Robb ML, Kublin JG, Gilbert PB, Corey L, Gray GE, McElrath MJ; HVTN 100 Protocol Team.

Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.

23.

Differences in the ability to predict and prepare for sexual activity between HIV-infected and HIV-uninfected young South African Women.

Sadeghi R, Alio A, Bennie T, Wallace M, Cai S, Abar B, Bekker LG, Adler D.

J AIDS HIV Res. 2018;10(1). pii: C75ADBC55797. doi: 10.5897/JAHR2017.0455. Epub 2018 Jan 31.

24.

Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.

Nel A, Martins J, Bekker LG, Ramjee G, Masenga G, Rees H, van Niekerk N.

PLoS One. 2018 May 29;13(5):e0196904. doi: 10.1371/journal.pone.0196904. eCollection 2018.

25.

Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.

Joseph Davey D, Farley E, Towriss C, Gomba Y, Bekker LG, Gorbach P, Shoptaw S, Coates T, Myer L.

PLoS One. 2018 May 14;13(5):e0197143. doi: 10.1371/journal.pone.0197143. eCollection 2018.

26.

Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa.

Dylla L, Abar B, Williamson AL, Meiring TL, Bekker LG, Adler DH.

J AIDS HIV Res. 2017 Oct;9(10):202-206. doi: 10.5897/JAHR2017.0445. Epub 2017 Oct 31.

27.

Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.

Figueroa DB, Tillotson J, Li M, Piwowar-Manning E, Hendrix CW, Holtz TH, Bokoch K, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant RM, Bumpus NN.

PLoS One. 2018 Apr 11;13(4):e0195764. doi: 10.1371/journal.pone.0195764. eCollection 2018.

28.

Feasibility and acceptability of conducting HIV vaccine trials in adolescents in South Africa: Going beyond willingness to participate towards implementation.

Wallace M, Middelkoop K, Smith P, Pike C, Bennie T, Chandia J, Churchyard G, Gray G, Latka MH, Mathebula M, Nchabeleng M, Roux S, Slack C, Strode A, Bekker LG.

S Afr Med J. 2018 Mar 28;108(4):291-298. doi: 10.7196/SAMJ.2017.v108i4.12909.

29.

Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa.

Powers KA, Price MA, Karita E, Kamali A, Kilembe W, Allen S, Hunter E, Bekker LG, Lakhi S, Inambao M, Anzala O, Latka MH, Fast PE, Gilmour J, Sanders EJ.

PLoS One. 2018 Apr 3;13(4):e0192785. doi: 10.1371/journal.pone.0192785. eCollection 2018.

30.

'Scared of going to the clinic': Contextualising healthcare access for men who have sex with men, female sex workers and people who use drugs in two South African cities.

Duby Z, Nkosi B, Scheibe A, Brown B, Bekker LG.

South Afr J HIV Med. 2018 Jan 19;19(1):701. doi: 10.4102/sajhivmed.v19i1.701. eCollection 2018.

31.

Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis.

Maljaars LP, Gill K, Smith PJ, Gray GE, Dietrich JJ, Gomez GB, Bekker LG.

South Afr J HIV Med. 2017 Sep 21;18(1):712. doi: 10.4102/sajhivmed.v18i1.712. eCollection 2017.

32.

Attitude shifts and knowledge gains: Evaluating men who have sex with men sensitisation training for healthcare workers in the Western Cape, South Africa.

Scheibe AP, Duby Z, Brown B, Sanders EJ, Bekker LG.

South Afr J HIV Med. 2017 Mar 31;18(1):673. doi: 10.4102/sajhivmed.v18i1.673. eCollection 2017.

33.

Adolescent lives matter: preventing HIV in adolescents.

Pettifor A, Stoner M, Pike C, Bekker LG.

Curr Opin HIV AIDS. 2018 May;13(3):265-273. doi: 10.1097/COH.0000000000000453.

34.

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G 3rd, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V.

PLoS Med. 2018 Mar 1;15(3):e1002514. doi: 10.1371/journal.pmed.1002514. eCollection 2018 Mar.

35.

A systematic review of contraceptive continuation among women living with HIV.

Todd CS, Anderman TC, Long S, Myer L, Bekker LG, Petro GA, Jones HE.

Contraception. 2018 Jul;98(1):8-24. doi: 10.1016/j.contraception.2018.02.002. Epub 2018 Feb 9.

PMID:
29432719
36.

A Conditional Economic Incentive Fails to Improve Linkage to Care and Antiretroviral Therapy Initiation Among HIV-Positive Adults in Cape Town, South Africa.

Maughan-Brown B, Smith P, Kuo C, Harrison A, Lurie MN, Bekker LG, Galárraga O.

AIDS Patient Care STDS. 2018 Feb;32(2):70-78. doi: 10.1089/apc.2017.0238.

PMID:
29432045
37.

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC.

AIDS. 2018 Mar 27;32(6):809-818. doi: 10.1097/QAD.0000000000001766.

38.

Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.

Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, Bekker LG.

PLoS One. 2018 Feb 8;13(2):e0191251. doi: 10.1371/journal.pone.0191251. eCollection 2018.

39.

Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine.

Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM.

Clin Infect Dis. 2018 Jul 18;67(3):411-419. doi: 10.1093/cid/ciy083.

PMID:
29415175
40.

Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP.

Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, van der Straten A.

AIDS Behav. 2018 Nov;22(11):3468-3479. doi: 10.1007/s10461-018-2044-2.

PMID:
29404757
41.

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM.

J Clin Virol. 2018 Feb - Mar;99-100:67-70. doi: 10.1016/j.jcv.2018.01.003. Epub 2018 Jan 11.

PMID:
29346085
42.

High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.

Mbulawa ZZA, van Schalkwyk C, Hu NC, Meiring TL, Barnabas S, Dabee S, Jaspan H, Kriek JM, Jaumdally SZ, Muller E, Bekker LG, Lewis DA, Dietrich J, Gray G, Passmore JS, Williamson AL.

PLoS One. 2018 Jan 2;13(1):e0190166. doi: 10.1371/journal.pone.0190166. eCollection 2018.

43.

Comparing four service delivery models for adolescent girls and young women through the 'Girl Power' study: protocol for a multisite quasi-experimental cohort study.

Rosenberg NE, Pettifor AE, Myers L, Phanga T, Marcus R, Bhushan NL, Madlingozi N, Vansia D, Masters A, Maseko B, Mtwisha L, Kachigamba A, Tang J, Hosseinipour MC, Bekker LG.

BMJ Open. 2017 Dec 14;7(12):e018480. doi: 10.1136/bmjopen-2017-018480.

44.

The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review.

Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker LG, Triant VA.

BMC Public Health. 2017 Dec 15;17(1):954. doi: 10.1186/s12889-017-4940-1. Review.

45.

Association of Adolescent- and Caregiver-Reported Antiretroviral Therapy Adherence with HIV Viral Load Among Perinatally-infected South African Adolescents.

Brittain K, Asafu-Agyei NA, Hoare J, Bekker LG, Rabie H, Nuttall J, Roux P, Stein DJ, Zar HJ, Myer L.

AIDS Behav. 2018 Mar;22(3):909-917. doi: 10.1007/s10461-017-2004-2.

PMID:
29224045
46.

Childbearing intentions among sexually active HIV-infected and HIV-uninfected female adolescents in South Africa.

Adler DH, Abar B, Bennie T, Sadeghi R, Bekker LG.

J AIDS HIV Res. 2017 Jul;9(7):159-163. doi: 10.5897/JAHR2017.0432. Epub 2017 Jul 31.

47.

Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.

Barnabas SL, Dabee S, Passmore JS, Jaspan HB, Lewis DA, Jaumdally SZ, Gamieldien H, Masson L, Muller E, Maseko VD, Mkhize N, Mbulawa Z, Williamson AL, Gray CM, Hope TJ, Chiodi F, Dietrich J, Gray G, Bekker LG; Women’s Initiative in Sexual Health (WISH) study team.

Int J STD AIDS. 2018 May;29(6):531-539. doi: 10.1177/0956462417740487. Epub 2017 Dec 4.

PMID:
29198180
48.

The end of HIV: Still a very long way to go, but progress continues.

Deeks SG, Lewin SR, Bekker LG.

PLoS Med. 2017 Nov 30;14(11):e1002466. doi: 10.1371/journal.pmed.1002466. eCollection 2017 Nov.

49.

The case for viral load testing in adolescents in resource-limited settings.

Marcus R, Ferrand RA, Kranzer K, Bekker LG.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25002. Review.

50.

Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.

Katz IT, Kaplan R, Fitzmaurice G, Leone D, Bangsberg DR, Bekker LG, Orrell C.

PLoS Med. 2017 Nov 14;14(11):e1002434. doi: 10.1371/journal.pmed.1002434. eCollection 2017 Nov.

Supplemental Content

Loading ...
Support Center